Modeling viral coevolution: HIV multi-clonal persistence and competition
  dynamics by Bagnoli, Franco et al.
ar
X
iv
:q
-b
io
/0
50
90
06
v1
  [
q-
bio
.PE
]  
7 S
ep
 20
05
Modeling viral coevolution: HIV multi-clonal
persistence and competition dynamics
F. Bagnoli a,c,1, P. Lio` b,2, L. Sguanci a,c,3
aDipartimento di Energetica, Universita` di Firenze, Via S. Marta 3, 50139
Firenze, Italy.
bComputer Laboratory, University of Cambridge, CB3 0FD Cambridge, UK.
cINFN, sezione di Firenze and CSDC.
Abstract
The coexistence of different viral strains (quasispecies) within the same host are
nowadays observed for a growing number of viruses, most notably HIV, Marburg
and Ebola, but the conditions for the formation and survival of new strains have
not yet been understood. We present a model of HIV quasispecies competition,
that describes the conditions of viral quasispecies coexistence under different im-
mune system conditions. Our model incorporates both T and B cells responses,
and we show that the role of B cells is important and additive to that of T cells.
Simulations of coinfection (simultaneous infection) and superinfection (delayed sec-
ondary infection) scenarios in the early stages (days) and in the late stages of the
infection (years) are in agreement with emerging molecular biology findings. The
immune response induces a competition among similar phenotypes, leading to dif-
ferentiation (quasi-speciation), escape dynamics and complex oscillations of viral
strain abundance. We found that the quasispecies dynamics after superinfection or
coinfection has time scales of several months and becomes even slower when the
immune system response is weak. Our model represents a general framework to
study the speed and distribution of HIV quasispecies during disease progression,
vaccination and therapy.
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1 Introduction
The human immune system has the goal of providing a basic defense against pathoge-
nic organisms [1,2]. The cells forming the immune system communicate via direct
contact and through chemical signals. Using a very basic schematization, the immune
system protective action can be divided into an innate, aspecific response, and an
adaptive one. This latter component involves two major types of cells: lymphocytes,
(T and B lymphocyte cells) and antigen presenting cells: monocytes, macrophages,
B cells and dendritic cells. Lymphocytes have the ability to react to specific epitopes,
which generally are portions of a protein. The idea is to recognize those shapes that
constitute a fingerprint of the presence of a foreign agent (antigen), but not to react
to self repertoire. Their response depends on the T cell receptor (TCR) of the T
cell, and immunoglobulins (Ig) of the B cells. It is the great variety of cells carrying
TCRs or secerning Igs that allows the recognition of all possible antigens.
Let us present a simplified description of the adaptive response, see Ref. [2] for a
physicists-oriented introduction to immune system modeling. The task of protecting
the body implies the detection and removal of free antigens, and the recognition
and suppression of infected (or cancer) cells. These deviating self cells are identified
by a sophisticated automatic mechanism, common to all cells, that presents on
their surface specific receptors along with epitopes. Both viral infection or cancer
proliferation implies the activation of novel genes, and thus the production of foreign
proteins that can thus be detected. However, due to the danger (and cost) of an
inflammation, the activation of the immune adaptive response is subject to a double
key protection, implemented by T helper cells.
T cells are divided into CD4+ (helper) and CD8+ (killer) types, according with
specific receptors present on their surface. CD4+ T cells provide the regulatory
mechanism that triggers the immune response by finding and presenting antigens
and releasing stimulatory signals (cytokines). T cells are specific for a given set
of epitopes; simplifying, we can say that they are specific for a given antigen. Once
activated, CD8+ T cells search for and kill other cells presenting the specific antigen.
Their action is triggered by CD4+ T cells recognizing that antigen. This specificity
is not absolute: there is a certain variability of receptors allowing cross-recognition
of similar epitopes.
The coverage of all possible shapes is implemented by a unique mechanism of ge-
netic combinatorial sampling. The protection against self recognition is due to the
maturation phase. Immature T lymphocytes are generated in the bone marrow and
then travel to the thymus where they proceed through a selection process. In the
thymus those CD4+ and CD8+ T cells that initiate any reaction against self shapes
are selected out.
B cells are responsible of the removal of extracellular antigens. Antigen specific
CD4+ T cells are required to induce proliferation of antigen specific B cells. The
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activated B cells then proliferate and differentiate into plasma cells. These produce
soluble counterparts to the cell’s receptors, called antibodies, which circulate in the
blood and fluids. Antibodies bind to specific extracellular antigens and allow them
to be removed by other means.
An antigen selects a “strain” of lymphocytes which replicates in response (clonal
response). During this growth, the specificity of receptors to a given antigen may be
increased by an hypermutation mechanism that slightly modifies the genes specifying
the receptor shapes. A few cells of this strain (memory cells) will persist for a long
time in the body, after viral eradication: should the specific antigen reappear, the
response will be faster and stronger (vaccination).
Let’s now describe the immune response in the framework of a HIV infection. HIV
infects cells that contain the CD4 receptor on their cell membrane, through which
the virus attaches and enters the cell. The CD4 molecules are found on T lymphocyte
helper cells, monocytes and macrophages.
As HIV uses the CD4 molecule to establish the initial binding to a cell, these cells
are the main target for HIV infection. Since CD4+ T cells are vital to the establish-
ment of an immune response, their progressive loss opens the way for AIDS-related
opportunistic infections [3].
The worldwide presence of several strains of the HIV virus and their often simultane-
ous presence within a patient, due to the increased frequency of multiple infections,
are the new remarkable features of HIV pandemia. For example, HIV-1, presently,
exists as three groups classified according to their degree of similarity. Group M
stands for main, Group O for outlier and Group N for non-M, non-O. Group M
is the predominant group and is divided into 9 strains (subtypes or strains) that
differ in the env gene [4,5]. Specific strains are predominant in different geographical
regions and their high mutation rates often allow researchers to track the network
of contacts. A growing number of strains within each subtype is nowadays reported.
The origin of different HIV strains is related to the quasispecies characteristics of
HIV evolution [6]. Quasispecies are the combined result of mutations and recombina-
tion, originating variability, and selection, that filters out this variability. The main
source of mutations is the reverse transcription phase [1], in which the viral RNA is
converted into DNA by viral proteins that are not very accurate. Other sources of
variability are the errors during the transcription phase, deletions and other genetic
rearrangements during the integration of viral DNA into the host chromosomes, in-
cluding recombination with other viral DNA or proviruses present in the cell. This
mechanism thus increases the viral diversity in the body. However, not all these vari-
ants have the same capability of completing their life cycle and multiplying their
clone number (i.e. their fitness).
First of all, the infection capacity of mutants may vary, and also their speed of
replication [7]. In some cases a single mutation is sufficient to alter significatively
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the fitness [8], or this may due to the accumulation of several mutations (smooth or
Fujiama landscape [9]). Since the number of targets (the substrate) is limited, the
strains that originate more clones in the unit of time tend to eliminate less fitness
mutants, which are subsequently regenerated by the mutation mechanism [10]. While
mutations are an essential ingredient for exploring the genetic space in the search for
the fitness maximum, they also lowers the average fitness of the strain, that generally
is formed by a cloud of mutants around the fitness maximum (quasispecies). For a
given fitness landscape, there is a maximum tolerable mutation rate above which
the quasispecies structure is lost (error catastrophe [6]).
The HIV quasispecies seem able to compete and their persistence affect AIDS pro-
gression [11,12]. For instance, some mutants may even be unable to colonize new
cells, but they may survive by parasitizing more invasive clones (this is particularly
observed when recombination of several strains is present) [13]. Finally, the immune
response is specific, with a certain tolerance, to a given antigen, and may vary from
antigen to antigen, due, for instance, to their similarities to self shapes. Thus, the
presence of an antigen originates an immune response that suppresses also variants of
the stimulating clone. This results in a form of competition among strains or clones,
that prefer to stay away in the genetic space in order to escape the immune response
and/or lower their intensity by dividing the productive capacity of the immune sys-
tem into several strains (multi-infection). The effect of this competition may result
in a continuously varying dominant quasispecies that tries to escape the immune
response, or the splitting of the quasispecies into multiple strains (quasi-speciation).
During the first phases of HIV infection, when the immune response is vigorous, the
first phenomenon is observed until presumably the virus finds a niche in the genetic
space, not sufficiently covered by the immune system, originating AIDS [14,15]. The
resistance to antiviral treatment may be ascribed to a similar mechanism. When the
immune system is depressed, also slightly less adapted strains may survive, giving
origin to multi-clonal infections often observed in terminal patients [16].
Secondary HIV infections with closely related strains may induce the response and
clonal selection of a new subsets of CD4+ T cells that recognize specifically the new
HIV strain, even under conditions of chronic infection by other strains. We can distin-
guish two scenarios: strains coinfection (simultaneous infection) and superinfection
(delayed secondary infection) scenarios (see for instance Refs. [17,18,19,20,21]).
Our aim is to model viral strain coevolution and understand the importance of
factors such as mutation rates, strength of immune response, cross-talks between T
and B cells and competition among strains in coinfection and superinfection.
The fate of an epidemic does not depend only on the evolution inside a single
host, but also on the transmissibility to other hosts. The social factors involved
in emergence of viral strains are diverse and include global transportation, urban
crowding and poverty, changing behavioral patterns, human population growth, etc.
[22]. We shall not deal with these aspects in the present paper.
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Fig. 1. Representation of the interactions between cells and/or cells and viruses. HIV
strains infect CD4+ T cells that become infected and produce new viruses. At the same
time HIV peptides are presented via APC cells to T-Helper cells that become activated.
Activated CD4+ T cells trigger B and CD8+ cells reactions: the first release antibodies
that bind to the antigen while the latter directly remove infected CD4+ T cells. ’+’ and
’-’ signs indicate cell/virus production or removal.
The article is organized in the following way: in the next sections we introduce a
model that combines T and B cells immune response to HIV infection. Then we
extend the model to include quasispecies and we test the model in the scenarios of
coinfection and superinfection using parameters derived from biological literature.
Finally we discuss results and work in progress.
In what follows, we shall use the terms strain and quasispecies, according with the
scale at which one is examining the system. In order to resolve the quasispecies
details, one needs to use a (genotypic or phenotypic) scale sufficiently fine to allow
differentiation inside a single quasispecies. On the contrary, if one is interested in the
ecological relations among quasispecies, it is more efficient to use a scale in which
a whole quasispecies is simply collapsed in a single value. In this latter case we use
the term strain to refer to the whole quasispecies.
2 Models
Mathematical models have proven valuable in understanding the mechanisms of
many of the observed features of HIV dynamics, such as the positive and negative
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regulation of T and B cell selection, the dynamics of production of the TCR reper-
toire in the thymus, the progression to and the latent phase of AIDS [15,23,24,25,26,27,28,29].
They have also been useful in forecasting the effects of multi drug therapy.
While the majority of HIV dynamics models assume that each CD4+ T cell is
infected by a single HIV strain, Dixit and Perelson [30] have shown that with the
progression of HIV infection multiple infections become very likely.
Our goal was to investigate the conditions of the multi-strains persistence within a
single patient and the effects of coinfection and superinfection. To set the scenarios
of our model, it is noteworthy that, in general, the immune response can be seen as
a prey/predator dynamics, in that the immune system is the predator of the virus
(the prey). The HIV dynamics is more complex because the HIV is both the prey
and the predator, i.e. it attacks CD4+ T cells and is attacked by cells coordinated
by CD4+ T cells.
Figure 1 illustrates the relationships among the different quantities of our model.
This schematization is valid for the quasispecies case and for the undifferentiated
one. In this latter case, the indication of strains (in parenthesis) should be neglected.
The clonal amplification of naive T cells (of population i) depends on the ability of
(ith class) T cell to recognize all the infected T cells (carrying an epitope from the
kth class of viruses). The rate of infection of naive T cells (of class i) depends on
all the viruses (containing the epitope k). In the same way, the clonal expansion of
infected T cells (of class k, meaning that they have been infected by a virus of class
k irrespective of the original T class) depends on the interaction of these viruses
with all the T cells (of any class i).
2.1 Combining B and T cells responses
Let us start from a widely accepted theoretical model of HIV progression and im-
mune response proposed by Perelson and colleagues in 1995 [15], recently extended
to include CTL response and stochastic components [23]. There are several works
that discuss the role of B cells in the immune response [14]. Since the progression
to AIDS has been found to correlate well with CD4+ T cells decrease, B cells are
thought to play a minor role in the immune response to HIV. Note that B cells can
act only as predator to the HIV, so their coupling with HIV dynamics is different
from that of T cells. Our aim is to present a more general model framework of both
T and B immune responses to HIV. We have first considered the following system
of differential equations describing the dynamics of a single viral strain:
T˙ =
(
λ+ γ(T )I T
)
(1− T/K)− (δT + β V ) T, (1)
I˙ = β V T −
(
δI + γ
(I) T
)
I, (2)
V˙ = pi I −
(
c+ γ(V ) T
)
V. (3)
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Fig. 2. Typical time evolution of the single-species model; diamonds represent uninfected
T cells, squares represent viruses and plus signs the infected T cells. Plot (a) illustrates
a scenario leading to a chronic infection (γ(T ) = 10−6, γ(I) = 10−5, γ(V ) = 0). In the
presence of a further B cell response (plot (b)), the infection is defeated by the immune
system (γ(T ) = 10−6, γ(I) = 10−5 and γ(V ) = 5 · 10−6).
All quantities indicated by greek letters and c have unit days−1.
This model considers the T-helper (CD4+) cells (T ), and HIV virus particles (V );
the T cells can become infected (I). With respect to Refs. [15,23], in Eq. (1), we
describe how the number of naive T cells (T ) which have passed the thymus selection,
depends on rate of formation in the bone marrow (λ), and on clonal amplification
upon stimulation by infected cells, I (term I T ). They decrease with a rate that is the
sum of a natural clearance, (δTT ), due to cell aging, and cell destruction upon virus
infection, (V T ). The density of T cells is limited by a saturating density/lymphonode
capacity factor, K. Following Ref. [28] we have set K = 1012.
The second equation describes the rate of infection, described by β, of naive T cells
upon the interaction with the virus (term V T ). Infected T cells are cleared out at
a fixed rate, δI , and due to the action of natural killer cells, CD8+ (term TI).
The third equation describes the budding of viruses from infected cells, pi. Virus par-
ticles are cleared out at rate c (defective viruses) and after immunoglobulin binding
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and subsequent engulfments by the macrophages (term TV ).
The γ parameters have the same meaning of the constant of association in chemistry,
or can be thought as a combination of both the probability of interaction and the
interaction strengths between cells (γ(T ),γ(I)) or between cells and viruses (γ(V )).
Note that in the limit γ → 0 and K → ∞, we recover the pattern of the standard
model [27].
The B cell response is modeled using the parameters corresponding to the T cells
which activate them by receptor recognition. Here, we have assumed the immunoglob-
ulin concentration, which represent the B cell response, are linearly correlated to the
concentration of activated B cells. These in turn are supposed linearly correlated to
the concentration of the CD4+ T cells. Exploratory analysis with different param-
eters, suggested us that Eq. (3) allows to keep a minimum number of parameters
without loss of important details.
Figure 2 shows some typical behavior of this single-species model, showing the case
of asymptotic coexistence of immune system and virus (chronical infection) and
virus eradication. This latter scenario may be triggered both by increasing the T
killer (γ(I)) or B (γ(V )) response. In no cases it is possible to observe the defeat
of the immune system, since a decrease of the quantity of T cells, affects also the
rate of viral production. This reflects the observed fact that progression to AIDS
and death is caused by opportunistic infections and not directly by the HIV virus.
Model parameters are derived from medical literature (see also Ref. [23]).
2.2 Modeling quasispecies competition and persistence
Our actual model is obtained by extending Eqs (1-3), to include the effects of qua-
sispecies persistence.
For the sake of simplicity, we assume that each viral strain is characterized by just
one epitope i. We make use of coupled differential equations, one for each viral
quasispecies and T cell. Although this mean-field approach disregards the effect of
fluctuations and genetic drift in quasispecies abundances, it is useful for understand-
ing the coarse-grain features of the behavior of the interplay between HIV and the
immune system.
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The quasispecies model is described by the following set of equations:
T˙i =
(
λi +
∑
k
γ
(T )
ik IkTi
)(
1−
1
K
∑
i
Ti
)
−
(
δT +
∑
k
βkVk
)
Ti, (4)
I˙k =
(∑
k′
µkk′βk′Vk′
)(∑
i
Ti
)
−
(
δI +
∑
i
γ
(I)
ki Ti
)
Ik, (5)
V˙k = piIk −
(
c+
∑
i
γ
(V )
ki Ti
)
Vk. (6)
The model considers the following cell types: T-helper (CD4+) cells responding to
virus strain i, (Ti); T cells (any strain) infected by virus strain k, (Ik); abundance of
viral strain k, (Vk). This means that viral strain k are identified by just one epitope,
which is then displayed on the surface of the T cell of class k, and that a T cell of
class i can be activated at least by one CD4+ T cell carrying the epitope k, which
is specific of the viral strain k. The indices i (k) range from 1 to Ni (Nk), and in the
following we have used Ni = Nk = N .
Equation (4) describes the generation of T cells through two mechanisms: the bone-
marrow source (and selection in the thymus) and the duplication of T cell strains
activated upon the recognition with an antigen carrying cell that may be even an
infected one. In order to take into account the limits of the immune response, we
have investigated both a logistic term and different types of saturating and density-
dependent functions [23]. The logistic term models the global carrying capacity of
immune system. In other works [23], a saturating function or density dependent
function was used, aiming to describe how the growth and development of the im-
mune response is limited by the timing of T cell division among other constraints
such as cell-cell recognition, signals diffusion, cell migration.
The death-rate term represents both a natural death rate proportional to the popu-
lation, and the infection rate of T cells by any viral strain. The infection probability,
reflected by the term
∑
k βkVkTi and by the sum over Ti in the I cell birth rate, is
the same irrespective of the T class. We assume that an infected T cell does no more
contribute to the immune response.
Equation (5) describes the infection dynamics. The incorporation of two death rate
parameters reflects the fact that the infected cells disappear due to cellular death
and after the action of natural killer cells (CD8+). There are clear experimental
evidences that CD4+ cells decrease during the late HIV infection stages and in the
AIDS state. In terms of our models this mean that the parameter δI depends on the
stage of the infection. We have preferred to model the early stage of infection, far
from AIDS conditions and therefore we have set δI to a constant, medical literature
referred, value.
The term µkk′ represents a mutation process that affect the phenotype. Mutations
occur mainly during the reverse transcriptase processing of the viral genomes. The
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mutation parameter is essential for the formation of new quasispecies. Although
RNA viruses have been reported to have substitution rates of the order of 1 · 10−3
substitution per site per replication [31]. Mansky and Temin [32] determined an in-
vivo mutation rate of 3.5·10−5. The majority of mutations does not change the amino
acids. Moreover, most of amino acid substitutions are neutral or quasi-neutral, since
they do not change remarkably the protein structure, and therefore the fitness of
the species; effective differences in fitness and behavior evolve through several amino
acid changes (see for instance [33]). Nevertheless, one single event of recombination
can often alter the fitness in a substantial way. We take into consideration only
those non-synonymous mutations that alter the phenotype (protein structure), and
therefore we used a slight smaller value for the mutation rate of the order of 10−5.
We have implemented the matrix µkk′ as a discrete Laplacian (diffusion in phenotypic
space) controlled by parameter µ (without indices).
Equation (6) describes the virus replicative dynamics in terms of a birth rate propor-
tional to the virus ”budding” numerosity. The viral death rate parameters depend
on the rate of natural death and on the recognition of virus by B cells.
As in the single-specie model, B-cells and T-killer cells are only implicitly included
in the model in order to reduce the dimensionality without loosing too many details.
We assume that these responses are fast enough to be at equilibrium and they are
just proportional to the abundance of (cognate) T helper cells.
While in the single-strain model, Eqs. (1-3), the three γ parameters are scalar values,
here γ
(T )
ik , γ
(I)
ki and γ
(V )
ki are matrices describing the interactions between viral strains
and immune cells, i.e. who will interact with whom. The γ parameters represent the
interaction between cells and/or cells and viruses in terms of geometry and strength
of the interaction. It expresses in a single matrix all the information about diffusion,
epitope recognition and show some analogies with a constant-in-time fitness, as
described in Ref. [34].
When the γ matrices are diagonal, each T cell interacts only with one viral strain.
The non-zero elements of the ith row in the γ matrices represent the strains of the
virus recognized by the immune cells of class i while the value represents the affinity
maturation, i.e. the accuracy in recognition.
In order to control the shape of the γ matrices with few parameters, we choose the
following functional form (see Fig. 3)
γij = A
{
1
2
[
1 + cos
(
2pi
N
(i− j)
)]}εA
+B
{
1
2
[
1 + cos
(
pi
N
(i+ j)
)]}εB
.
The parameters A and εA (B and εB) control the shape of the γ matrices in the di-
rection transverse (parallel) to the main diagonal. The exponents εA and εB controls
the smoothness of the variation along the corresponding direction. For ε small the
variation of the function is very small, while for ε→∞ the corresponding function
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Fig. 3. Control parameters and shape of the γ-matrices
is δ-shape. So, a diagonal γ matrix is obtained by setting B = 0 and εA large. For
instance, differences in the fitness of phenotypes may be obtained by setting B and
εB different from zero in some of the γ-matrices, while the intra-species competition
is triggered by setting A different from zero and εA small.
It is worth noting that nowadays, 2-photons experiments allow to measures recog-
nition strength, movements and speed of the immune cells [35] that, in theory, can
be used to derive estimates of the γ matrices. We think that this data is still in
embryonal phase, so we focus on the qualitatively features of the response.
Given the absence of a precise relationship between genotype and phenotype changes,
we have simply considered the grouping together all quasispecies with the same fit-
ness. Thus the quasispecies constitute a linear space ordered in term of phenotype
similarity.
We have used the same values of model parameters by re-scaling T, I, V , λi and K
by the number N of strains.
3 Numerical results
The evolution of T cells abundances in a scenario of quasispecies is shown in 4. Note
that when the asymptotic state of our model is given by a fixed point, the asymptotic
distribution is insensitive of the initial conditions, and the strains corresponding to
higher fitness are more abundant. However, one should consider that this asymptotic
state may be reached after such a long time that it may be outside any practical
scenario of the progression of a disease. The role of mutations in the transitory
regime is quite particular. First of all, mutations are necessary to populate strains
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Fig. 4. Typical time evolution of the T cell abundance in the multi-species model for
short-term (a) and long-term behavior (b). We set µ = 10−5, A = 5 · 10−6, εA = 10,
B(T ) = 3 · 10−6, ε
(T )
B = 10 with N = 5. In the inset, the y-axis on the left reports
the asymptotic abundance of virus strains, the y-axis on the right shows the interaction
strength (dashed line) between T cells and virus phenotypes (x-axis).
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Fig. 5. Phase space analysis of As parameters of the γ matrices. In plot (a) we fix
A(V )=10−6 and we show A(I) vs. A(T ). In plot (b) we fix A(I)=10−6 and we show A(V ) vs.
A(T ). In plot (c) we fix A(T )=10−6 and we show A(V ) vs. A(I). The other parameters are:
number of quasi species N = 25, εA = 10
3, B = 0 and µ = 0. Region I corresponds to the
coexistence of immune system and viruses (chronic infection) while region II corresponds
to the defeat of viral infection.
outside the first inoculum, see also Fig. 6. Mutations affect also the average fitness
and the width of the quasispecies and the Eigen’s error threshold [36] is a sort
of extremal consequence of this effect. However, in the presence of coupling among
strains, due to competition or to a global constraints (the K parameter), the specific
form of mutations does not play a fundamental role, see also Ref. [34].
It’s noteworthy that a naive analogy between evolutionary systems and statistical
mechanics can be obtained by identifying the selection as the (opposite) of energy
and mutation as a sort of temperature ([37,38]).
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3.1 Phase diagrams of γ matrices
We focused our attention on the parameter A of the three γ matrices which repre-
sent the major features of the interaction, Fig. 5. The regions I and II in the three
diagrams represent chronic infection (coexistence of immune system and viral in-
fection) and complete recovery (virus defeat) from the disease, respectively. For the
sake of clarity instead of 3D diagrams, we choose 2D projections, after setting the
other dimension to a biologically meaningful value.
The effect of B cells is shown in Fig. 5a : for a very low contribution of B cells to
the immune response, there is a clear threshold effect on both γ(T ) and γ(I). By
considering a weak action of T killer cells, the threshold effect for γ(T ) and γ(V ) (B
cells effect) is somewhat decreased but still present, Fig. 5b. Instead, Fig. 5c shows
that the combined effects of B and T cells are almost additive, despite the parameter
K that limits the total population of T cells. For example, let’s look at diagram (c).
If we draw a line at A(I) = 2.56 · 10−4, that is an extreme value for coexistence in
diagram (a), we can notice that both the two phases are present, in particular there
are values of A(V ) leading to the defeat of the infection.
3.2 Coinfection dynamics
The effect of competitive evolution observed after a single inoculum of two different
HIV strains at time t = 0 is shown in Fig. 6. We have considered two different
scenarios. The first one (Fig. 6a-b) represents the time evolution of T cells and viruses
when the epitopes of two different strains are subjected to the same interaction
strength. The second scenario (Fig. 6c-d) considers differences in the recognition
ability of viral antigens by T cells. For example, variants of the CCR5 receptors may
induce partial resistance against HIV [39]. De Boer and Perelson have shown [25]
that the phase space of the antigen-T cell recognition is not homogeneous but it is
patched with areas of strong immune response and areas of lack of immune response.
This difference in the strains targeted by the T cells generates changes in the fitness
of the virus that turn into differences in their abundances. The immune system
response is almost the same in the two cases, and very similar to that obtained
without considering the phenotypic space, Fig. 2. The asymptotic distribution of
viruses reflects the behavior of the fitness is induced by the stimulation of the immune
response, γ
(T )
ii , as in Fig. 4.
3.3 Superinfection dynamics
Results of short time and long term viral coevolution after superinfection are re-
ported Figs. 7 and 8, respectively. In both figures the first viral inoculum occurs at
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Fig. 6. Time evolution of T (plots (a) and (c)) and V (plots (b) and (d)) populations after
an inoculum with two strains (phenotypes 0 and 2), µ = 0, A = 5 · 10−6, εA = 10, N = 5.
Plots (a) and (b): B = 0; Plots (c) and (d): B(T ) = 3 · 10−6, ε
(T )
B = 10. In the inset the
asymptotic distribution of T and V populations and the shape of the diagonal of γ(T ) are
shown.
time t = 0 and the second infection at time t = 20, when the immune response to
the first inoculum has completed and the virus has established a chronic infection.
After the second inoculum and a short transient, a slow mounting of the second
viral infection occurs. This low dynamics continues on a scale of several months
(Figure 8) and eventually reaches the same level of the other quasispecies. This be-
havior represents another example of a slow relaxation to a fixed-point equilibrium.
With the progression of the disease, when the immune system is compromised (low
number of T cells i.e. low λ), a second inoculum strain requires a very long time to
reach the same abundances of the first strain (Fig. 8b).
Experimental evidences [13] show that the probability of observing new fitter recom-
binant strains increases with the number of already coevolving strains. This effect
has not been yet incorporated into our model.
3.4 Coevolution and speciation
Finally, we have studied virus quasispecies formation in more details. Figure 9a
shows the initial inoculum at phenotype 15 in a space of 25, followed by a delayed
inoculum at phenotype 5 at time t = 1. The non-uniform interaction strength would
favor the central phenotypes. However, since in this simulation the immune system
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Fig. 7. Short time behavior of uninfected T cells (a), infected T cells (b) and viruses (c)
under superinfection. Parameters as in Fig. 6a-b.
does not discriminate among similar phenotypes (modeled by ε
(T )
A = 10), there
is an induced competition among neighboring strains. This competition induces a
separation of the original quasi-species into two clusters (quasi-speciation), Fig. 9b.
However, as shown by Figs. 9c-d the immune system response continues to change
in time, resulting into a complex coevolution with viral populations. Fig. 10 shows
the typical irregular evolution of a speciation dynamics.
4 Discussion
We presented a model of the within-patience persistence of HIV quasispecies. We
have first extended the Perelson’s standard model [27] to incorporate B cells re-
sponse. The B cells, once activated by specific T cells, can only act as a predator,
and not being directly targeted as a prey by HIV. We found that this role represents
a non negligible contribution to the immune response in all cases where a virus or
bacterium is targeting (and being targeted by) T cells. Interestingly, T cells have a
role in both innate and adaptive immune responses while B cells only in the adap-
tive system. It is known that the innate immune response is present also in insects
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Fig. 8. Long time behavior of virus abundances after superinfection at time t = 20. (a)
healthy immune system (λ = 105); (b) weak immune system (λ = 104). The other param-
eters used have the same values of Fig. 6a-b. Diamonds represent the first inoculum and
squares the second inoculum.
while the adaptive is more recent, being present only in vertebrate. Thus, B cells
may have appeared also to fight back viruses targeting specifically at T cells.
Recent works have shown that HIV quasispecies may compete [11] and that persis-
tence of the initial or ancestor quasispecies is a good indicator for disease progression
[12].
Our model shows that the time evolution of the competition between quasispecies
is slow and has time scales of several months. This provides a hint of why standard
viral dynamics models, which ignore multiple infections, are effective in describing
viral load evolution in HIV-infected individuals.
Burch and Chao [40] have stressed that the evolution of an RNA virus is determined
by its mutational neighborhood. As the phenotype divergence among viral strains
arises from differences in selection pressure, these differences may lead, for instance,
to a higher infection rate. Since the competition is through the immune system
response and given that the phase space of antigen recognition is not homogeneously
covered [14], the HIV high mutation rate allows the quasispecies to find regions with
weak immune response. This competition may lead to speciation of viral strains.
The introduction or modulation of a quasispecies may be used in therapy against
an already present aggressive strain. This would be particularly effective during full
AIDS stage when virus burden is particularly high and more stringent conditions
for competition. It is noteworthy that Schnell and colleagues [41] have constructed
a recombinant vesicular stomatitis virus that although unable to infect normal cells,
infected and killed cells that were first infected with HIV causing a rapid cytopathic
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Fig. 9. Speciation of virus quasispecies and uninfected T cells dynamics after competitive
superinfection at four different times: t = 0 (a), t = 4.5 (b), t = 5.25 (c) and t = 5.75
(d). Virus strain 15 is present at time t = 0, while strain 5 is inoculated at time t = 1.
Mutation rate µ = 10−4 and non-uniform interaction strength as in Fig. 6c-d. The dashed
line represents the abundances of T cells targeting each viral phenotype.
infection. The authors showed that the introduction of this engineered virus can
achieve HIV load reduction of 92% and recovery of host cells to 17% of their normal
levels (see also the mathematical model in Ref. [42]).
Our model represents a general framework to investigate several aspects of the evolu-
tion of HIV infections, for example intermittency or switching dominance of strains
and the arising of new dominant strains during different phases of therapy; how
superinfection will evolve in case of replacement of drug-resistant virus with a drug-
sensitive virus and acquisition of highly divergent viruses of different strains. It is
also useful to investigate whether antiviral treatment may increase susceptibility to
superinfection by decreasing antigen load. Different drug treatments can alter the
population of quasispecies. Quasispecies may be the key for both understanding the
emerging infectious diseases and has implications for transmission, public health
counselling, treatment and vaccine development.
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